Evidence map›Paper›PMID 41846066›Full record

ArticleEuropean journal of radiology2026

Image registration improves inter-reader agreement of objective response in CT assessment of pancreas adenocarcinoma.

Jon S Heiselman, Natally Horvat, Maria El Homsi, Burcin Agridag-Ucpinar, Onur Yildirim, Mithat Gonen, Brett L Ecker, Eileen M O'Reilly, Jeffrey A Drebin, Vinod P Balachandran and 7 more

Abstract read
In one paragraph

Article in European journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jon S HeiselmanDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA; Department of Biomedical Engineering, Vanderbilt University, 1225 Stevenson Center Lane, Nashville, TN, 37235, USA. Electronic address: jon.s.heiselman@vanderbilt.edu.
Natally HorvatDepartment of Radiology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Maria El HomsiDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Burcin Agridag-UcpinarDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Onur YildirimDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Mithat GonenDepartment of Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Brett L EckerDivision of Surgical Oncology, Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ 08901, USA.
Eileen M O'ReillyDepartment of Medical Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Jeffrey A DrebinDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Vinod P BalachandranDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
T Peter KinghamDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Kevin C SoaresDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Michael I D'AngelicaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Richard K G DoDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
William R JarnaginDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Alice C WeiDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Jayasree ChakrabortyDepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Total Neoadjuvant Therapy (TNT) for Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaP50CA257881 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Christine A Iacobuzio-Donahue · 2022 to 2026
$14.3M
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA257881
6 · The paper itself

Abstract

objectivesPancreatic ductal adenocarcinoma (PDAC) exhibits ill-defined appearance on imaging during neoadjuvant therapy (NAT), which may limit consistency of dimensional measurements for objective response. This study evaluates inter-reader variability of current clinical measures of tumor size and interval response between baseline and restaging CT, and compares reader reliability with and without image registration assistance.

methodsTwo senior and two junior radiologists retrospectively reviewed imaging of resectable PDAC patients enrolled in an IRB-approved Phase II clinical trial. Readers segmented lesion volumes from baseline and restaging CT and measured axial plane diameters to evaluate therapeutic response according to RECIST v1.1 and WHO criteria. Reliability of criteria index measures were compared with a computer-assisted image registration approach. Inter-reader agreements were quantified via generalized conformity index (GCI), concordance correlation coefficient (CCC), and Fleiss' Kappa (k). Statistical analyses were performed with significance level α = 0.05.

resultsBaseline and restaging imaging of 30 patients (67 ± 10y, 50% female) were evaluated. Inter-reader agreements of segmented tumor volumes at baseline/restaging were low (junior: GCI = 0.42/0.35, CCC = 0.36/0.68; senior: GCI = 0.43/0.39, CCC = 0.62/0.96; all readers: GCI = 0.43/0.38, CCC = 0.66/0.78). Agreements in percent change in tumor size differed by experience level (longest diameter: CCC = 0.26/0.77/0.59, p < 0.01; diameter product: CCC = 0.32/0.86/0.66, p < 0.001) and produced low kappa agreements (RECIST: k = 0.0/0.37/0.23, p < 0.01; WHO: k = 0.0/0.31/0.18, p = 0.01 [junior/senior/all readers]). Image registration-assisted tumor response produced higher agreements across all levels of reader experience (k = 0.82/0.80/0.81, p < 0.01; CCC = 0.83/0.95/0.91, p < 0.05 [junior/senior/all readers]).

conclusionSubstantial measurement variability exists in CT assessment of PDAC tumor response during NAT. Longitudinal image registration improves reproducibility and diminishes experience gap in radiologist assessments of objective response.

Indexed as

AdenocarcinomaCarcinoma, Pancreatic DuctalPancreatic NeoplasmsRadiographic Image Interpretation, Computer-AssistedSubtraction TechniqueTomography, X-Ray ComputedAgedClinical Trials, Phase II as TopicFemaleHumansMaleMiddle AgedObserver VariationRadiographic Image EnhancementReproducibility of ResultsSensitivity and SpecificityAgreementImage registrationObjective responsePancreas cancerRECISTReproducibility

Identifiers

PMID41846066
PMCPMC13246015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.